These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


246 related items for PubMed ID: 21220243

  • 1. Myocardial fibrosis detected by cardiac magnetic resonance imaging in heart failure: impact on remodeling, diastolic function and BNP levels.
    Babür Güler G, Karaahmet T, Tigen K.
    Anadolu Kardiyol Derg; 2011 Feb; 11(1):71-6. PubMed ID: 21220243
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping.
    Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ.
    J Am Coll Cardiol; 2008 Nov 04; 52(19):1574-80. PubMed ID: 19007595
    [Abstract] [Full Text] [Related]

  • 3. The effect of cardiac fibrosis on left ventricular remodeling, diastolic function, and N-terminal pro-B-type natriuretic peptide levels in patients with nonischemic dilated cardiomyopathy.
    Karaahmet T, Tigen K, Dundar C, Pala S, Guler A, Kilicgedik A, Cevik C, Mahmutyazicioglu K, Isiklar I, Basaran Y.
    Echocardiography; 2010 Sep 04; 27(8):954-60. PubMed ID: 20849483
    [Abstract] [Full Text] [Related]

  • 4. Application of magnetic resonance imaging in vivo for the assessment of the progression of systolic and diastolic dysfunction in a mouse model of dilated cardiomyopathy.
    Drelicharz Ł, Woźniak M, Skórka T, Tyrankiewicz U, Heinze-Paluchowska S, Jabłońska M, Gebska A, Chłopicki S.
    Kardiol Pol; 2009 Apr 04; 67(4):386-95. PubMed ID: 19492251
    [Abstract] [Full Text] [Related]

  • 5. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.
    Takeda K, Matsumiya G, Matsue H, Hamada S, Sakaki M, Sakaguchi T, Fujita T, Sawa Y.
    J Thorac Cardiovasc Surg; 2008 Dec 04; 136(6):1514-21. PubMed ID: 19114200
    [Abstract] [Full Text] [Related]

  • 6. Assessment of nonischemic myocardial fibrosis.
    Jellis C, Martin J, Narula J, Marwick TH.
    J Am Coll Cardiol; 2010 Jul 06; 56(2):89-97. PubMed ID: 20620723
    [Abstract] [Full Text] [Related]

  • 7. Relation of B-type natriuretic peptide to left ventricular wall stress as assessed by cardiac magnetic resonance imaging in patients with dilated cardiomyopathy.
    Alter P, Rupp H, Rominger MB, Vollrath A, Czerny F, Klose KJ, Maisch B.
    Can J Physiol Pharmacol; 2007 Aug 06; 85(8):790-9. PubMed ID: 17901889
    [Abstract] [Full Text] [Related]

  • 8. Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease.
    Syed IS, Martinez MW, Feng DL, Glockner JF.
    Int J Cardiol; 2008 Jun 06; 126(3):e50-2. PubMed ID: 17399811
    [Abstract] [Full Text] [Related]

  • 9. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.
    Maron MS, Appelbaum E, Harrigan CJ, Buros J, Gibson CM, Hanna C, Lesser JR, Udelson JE, Manning WJ, Maron BJ.
    Circ Heart Fail; 2008 Sep 06; 1(3):184-91. PubMed ID: 19808288
    [Abstract] [Full Text] [Related]

  • 10. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
    Orn S, Manhenke C, Squire IB, Ng L, Anand I, Dickstein K.
    J Card Fail; 2007 Dec 06; 13(10):843-9. PubMed ID: 18068618
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Magnetic resonance imaging assessment of reverse left ventricular remodeling late after restrictive mitral annuloplasty in early stages of dilated cardiomyopathy.
    Westenberg JJ, Braun J, Van de Veire NR, Klautz RJ, Versteegh MI, Roes SD, van der Geest RJ, de Roos A, van der Wall EE, Reiber JH, Bax JJ, Dion RA.
    J Thorac Cardiovasc Surg; 2008 Jun 06; 135(6):1247-52; discussion 1252-3. PubMed ID: 18544363
    [Abstract] [Full Text] [Related]

  • 13. The role of cardiovascular magnetic resonance imaging in heart failure.
    Karamitsos TD, Francis JM, Myerson S, Selvanayagam JB, Neubauer S.
    J Am Coll Cardiol; 2009 Oct 06; 54(15):1407-24. PubMed ID: 19796734
    [Abstract] [Full Text] [Related]

  • 14. Reverse-remodeling after coronary artery bypass grafting in ischemic cardiomyopathy: assessment of myocardial viability by delayed-enhanced magnetic resonance imaging can help cardiac surgeons.
    Ogawa M, Doi K, Fukumoto A, Yaku H.
    Interact Cardiovasc Thorac Surg; 2007 Oct 06; 6(5):673-5. PubMed ID: 17670732
    [Abstract] [Full Text] [Related]

  • 15. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C, Maria Sironi A, Favilli B, Poletti R, Prontera C, Ripoli A, Lombardi M, Emdin M.
    Int J Cardiol; 2005 Sep 15; 104(1):39-45. PubMed ID: 16137508
    [Abstract] [Full Text] [Related]

  • 16. Insights of prognostication of Davies disease: what could we learn from serial magnetic resonance imaging studies?
    Cheung SC, Chan CW.
    Int J Cardiol; 2010 Jul 09; 142(2):e32-4. PubMed ID: 19144428
    [Abstract] [Full Text] [Related]

  • 17. Pathophysiology of heart failure following myocardial infarction.
    Struthers AD.
    Heart; 2005 May 09; 91 Suppl 2(Suppl 2):ii14-6; discussion ii31, ii43-8. PubMed ID: 15831601
    [Abstract] [Full Text] [Related]

  • 18. An unusual association of endomyocardial fibrosis and hypertrophic cardiomyopathy in a patient with heart failure.
    Salemi VM, D'andretta Iglezias S, Benvenuti LA, Filho JC, Rochitte CE, Shiozaki AA, Mady C.
    Cardiovasc Pathol; 2012 May 09; 21(2):e23-5. PubMed ID: 21641824
    [Abstract] [Full Text] [Related]

  • 19. Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart.
    Ogawa Y, Tamura N, Chusho H, Nakao K.
    Can J Physiol Pharmacol; 2001 Aug 09; 79(8):723-9. PubMed ID: 11558681
    [Abstract] [Full Text] [Related]

  • 20. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging.
    Popović ZB, Kwon DH, Mishra M, Buakhamsri A, Greenberg NL, Thamilarasan M, Flamm SD, Thomas JD, Lever HM, Desai MY.
    J Am Soc Echocardiogr; 2008 Dec 09; 21(12):1299-305. PubMed ID: 19041572
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.